| Accession Number: | 0001593968-23-000491 |
| Date: | 2023-03-14 |
| Issuer: | ALLOGENE THERAPEUTICS, INC. (ALLO) |
| Original Submission Date: |
BHAVNAGRI VEER
210 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-03-14 | F | 23,628 | d | $5.67 | 556,049 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|---|
| f1 | represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. this sale is mandated by the issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. |
| f2 | includes 2,000 shares of the issuer's common stock acquired by the reporting person on march 15, 2023 pursuant to an employee stock purchase program. |
